These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 31545528
1. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease. Kulessa M, Weyer-Menkhoff I, Viergutz L, Kornblum C, Claeys KG, Schneider I, Plöckinger U, Young P, Boentert M, Vielhaber S, Mawrin C, Bergmann M, Weis J, Ziagaki A, Stenzel W, Deschauer M, Nolte D, Hahn A, Schoser B, Schänzer A. Neuropathol Appl Neurobiol; 2020 Jun; 46(4):359-374. PubMed ID: 31545528 [Abstract] [Full Text] [Related]
5. Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families. Napolitano F, Bruno G, Terracciano C, Franzese G, Palomba NP, Scotto di Carlo F, Signoriello E, De Blasiis P, Navarro S, Gialluisi A, Melone MAB, Sampaolo S, Esposito T. Int J Mol Sci; 2021 Mar 31; 22(7):. PubMed ID: 33807278 [Abstract] [Full Text] [Related]
6. The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients. Feeney EJ, Austin S, Chien YH, Mandel H, Schoser B, Prater S, Hwu WL, Ralston E, Kishnani PS, Raben N. Acta Neuropathol Commun; 2014 Jan 02; 2():2. PubMed ID: 24383498 [Abstract] [Full Text] [Related]
7. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant. Rairikar MV, Case LE, Bailey LA, Kazi ZB, Desai AK, Berrier KL, Coats J, Gandy R, Quinones R, Kishnani PS. Mol Genet Metab; 2017 Nov 02; 122(3):99-107. PubMed ID: 28951071 [Abstract] [Full Text] [Related]
11. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Herzog A, Hartung R, Reuser AJ, Hermanns P, Runz H, Karabul N, Gökce S, Pohlenz J, Kampmann C, Lampe C, Beck M, Mengel E. Orphanet J Rare Dis; 2012 Jun 07; 7():35. PubMed ID: 22676651 [Abstract] [Full Text] [Related]
13. Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease. Moriggi M, Capitanio D, Torretta E, Barbacini P, Bragato C, Sartori P, Moggio M, Maggi L, Mora M, Gelfi C. Int J Mol Sci; 2021 Mar 11; 22(6):. PubMed ID: 33799647 [Abstract] [Full Text] [Related]
17. Quantification of muscle pathology in infantile Pompe disease. Schänzer A, Kaiser AK, Mühlfeld C, Kulessa M, Paulus W, von Pein H, Rohrbach M, Viergutz L, Mengel E, Marquardt T, Neubauer B, Acker T, Hahn A. Neuromuscul Disord; 2017 Feb 11; 27(2):141-152. PubMed ID: 27927596 [Abstract] [Full Text] [Related]
18. BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients. Carrasco-Rozas A, Fernández-Simón E, Suárez-Calvet X, Piñol-Jurado P, Alonso-Pérez J, de Luna N, Schoser B, Meinke P, Domínguez-González C, Hernández-Laín A, Paradas C, Rivas E, Illa I, Olivé M, Gallardo E, Díaz-Manera J. Am J Pathol; 2022 Aug 11; 192(8):1151-1166. PubMed ID: 35605642 [Abstract] [Full Text] [Related]
19. [Two new mutations in the gene that codes for acid alpha-glucosidase in an adolescent with late-onset Pompe disease]. Guevara-Campos J, Romeo-Villarroel MA, González-De Guevara L, Escobar V. Rev Neurol; 2013 Sep 16; 57(6):265-8. PubMed ID: 24008937 [Abstract] [Full Text] [Related]